Top

Journal of Experimental & Clinical Cancer Research

Published in:

Open Access 01-12-2017 | Erratum

Erratum to: The role of the AMOP domain in MUC4/Y-promoted tumour angiogenesis and metastasis in pancreatic cancer

Authors: Jie Tang, Yi Zhu, Kunling Xie, Xiaoyu Zhang, Xiaofei Zhi, Weizhi Wang, Zheng Li, Qun Zhang, Linjun Wang, Jiwei Wang, Zekuan Xu

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2017

Excerpt

In the original publication of this article [1], the funding number of the NSFC-NIH project was listed incorrectly. This should have been 81361120398, and not 812111519, which belongs to the researching project of another group. …

Tang, et al. The role of the AMOP domain in MUC4/Ypromoted tumour angiogenesis and metastasis in pancreatic cancer. J Exp Clin Cancer Res. 2016;35:91. doi:10.1186/s13046-016-0369-0.CrossRefPubMedPubMedCentral

Title: Erratum to: The role of the AMOP domain in MUC4/Y-promoted tumour angiogenesis and metastasis in pancreatic cancer
Authors: Jie Tang
Yi Zhu
Kunling Xie
Xiaoyu Zhang
Xiaofei Zhi
Weizhi Wang
Zheng Li
Qun Zhang
Linjun Wang
Jiwei Wang
Zekuan Xu
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: Journal of Experimental & Clinical Cancer Research / Issue 1/2017
Electronic ISSN: 1756-9966
DOI: https://doi.org/10.1186/s13046-017-0505-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma

FOXA1 inhibits hepatocellular carcinoma progression by suppressing PIK3R1 expression in male patients

RERG suppresses cell proliferation, migration and angiogenesis through ERK/NF-κB signaling pathway in nasopharyngeal carcinoma

Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness

PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a

MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2

Keynote webinar | Spotlight on antibody–drug conjugates in cancer